6 search results found
  • Past Deadline: Oct 15, 2020

    Sanofi’s MassBio Day of Partnering Opportunities for Innovative Life Science Startups

    partnership

    Amgen launches 2020 LabCentral Golden Ticket competition for innovative life science startups, awarding two startups with with lab space, amenities, and services.

  • Past Deadline: Aug 17, 2021

    Bristol Myers Squibb's LabCentral 2021 Golden Ticket Contest for life science startups

    partnership

    The Bristol Myers Squibb 2021 Golden Ticket Contest is a competition for the award of two Golden Tickets, which covers the cost of one 6-ft lab bench and one resident scientist fee for one year for a promising life science start-up.

  • Immunai

    New York, NY
    Immunai is an end-to-end computational immunology company leveraging the power of single-cell biology and AI to decode the Immune System to improve health and accelerate therapeutics.
    Keywords:
    single-cell sequencing, single-cell genomics, machine learning, Artificial Intelligence

  • Vaxess Technologies, Inc.

    Cambridge, MA
    Biotechnology
    Vaxess Technologies is a venture-backed biotechnology company developing novel products based on its proprietary MIMIX microneedle delivery platform. Our lead program is a sustain-release flu microneedle patch. We also have a pipeline of undisclosed targets including mRNA, immun/ooncology and other... More

  • Cracking Cancer 2.0 - Lightning Talks

    December 7, 2017 | Startup Exchange Video | Duration: 30:6

    Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.

  • Cracking Cancer 2.0 - Panel Discussion

    December 7, 2017 | Startup Exchange Video | Duration: 47:30

    Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.